Inventor
Marije OVERDIJK
Inventor
NL
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
A61KPreparations for medical, dental or toiletry purposes23%
G01NInvestigating or analysing materials by determining their chemical or physical properties19%
C12NMicroorganisms or enzymes4%
PatentTitleYear
12,577,316Methods of use of anti-CD37 antibodies, monoclonal anti-CD37 antibodies202612,448,459Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof202512,351,650Antibodies binding to fibroblast activation protein alpha and death receptor 4202512,247,080Anti-DR5 antibodies and methods of use thereof202512,173,076Polypeptide variants and uses thereof202411,512,137Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof202211,396,553Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to GENMAB HOLDING B V (4)· patent assignee history
2022–2026Based in NL· patent location history
2024–2025Patents assigned to GENMAB BV (2)· patent assignee history
2025Patents assigned to GENMAB AS (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENMAB HOLDING B V | 4 | 2022–2026 |
| GENMAB BV | 2 | 2024–2025 |
| GENMAB AS | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| NL | 7 | 2022–2026 |